Inventor · disambiguated record
Carlos Coito
Also filed as: COITO CARLOS
26 granted patents·12 pending applications·70 citations·filing 2009–2021
94Inventor score
Top patents by PatentIndex Score
38 records- 0193US8318690B2Treatment of hemoglobin (HBF/HBG) related diseases by inhibition of natural antisense transcript to HBF/HBGCOLLARD JOSEPH·Filed 2010·Granted Nov 27, 2012·27 cites·20 claims
- 0292US9771579B2Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNACOLLARD JOSEPH·Filed 2011·Granted Sep 26, 2017·22 cites·12 claims
- 0381US10793857B2Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNACURNA INC·Filed 2017·Granted Oct 6, 2020·1 cites·10 claims
- 0481US10604755B2Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism geneCURNA INC·Filed 2015·Granted Mar 31, 2020·2 cites·15 claims
- 0580US9074210B2Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNFCOLLARD JOSEPH·Filed 2010·Granted Jul 7, 2015·4 cites·13 claims
- 0679US9528110B2Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAPCURNA INC·Filed 2015·Granted Dec 27, 2016·2 cites·16 claims
- 0778US10113166B2Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activityCURNA INC·Filed 2014·Granted Oct 30, 2018·2 cites·15 claims
- 0878US2022195439A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2021·Application pending·0 cites
- 0977US9089588B2Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)COLLARD JOSEPH·Filed 2011·Granted Jul 28, 2015·3 cites·12 claims
- 1076US9708604B2Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1COLLARD JOSEPH·Filed 2010·Granted Jul 18, 2017·2 cites·12 claims
- 1174US9902958B2Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLGCURNA INC·Filed 2016·Granted Feb 27, 2018·1 cites·11 claims
- 1272US9725756B2Treatment of ‘C terminus of HSP7O-interacting protein’ (CHIP) related diseases by inhibition of natural antisense transcript to CHIPCURNA INC·Filed 2014·Granted Aug 8, 2017·1 cites·15 claims
- 1371US11390868B2Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activityCURNA INC·Filed 2018·Granted Jul 19, 2022·0 cites·12 claims
- 1471US10519448B2Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNFCURNA INC·Filed 2015·Granted Dec 31, 2019·1 cites·15 claims
- 1571US2020291407A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2020·Application pending·0 cites
- 1670US9464287B2Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2COLLARD JOSEPH·Filed 2010·Granted Oct 11, 2016·1 cites·8 claims
- 1766US2019040394A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2018·Application pending·0 cites
- 1864US10214745B2Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNFSCRIPPS RESEARCH INST·Filed 2017·Granted Feb 26, 2019·1 cites·23 claims
- 1962US2013137751A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2013·Application pending·0 cites
- 2060US10465192B2Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1CURNA INC·Filed 2017·Granted Nov 5, 2019·0 cites·13 claims
- 2160US10435690B2Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUACURNA INC·Filed 2017·Granted Oct 8, 2019·0 cites·8 claims
- 2257US9222088B2Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUACOLLARD JOSEPH·Filed 2011·Granted Dec 29, 2015·0 cites·17 claims
- 2356US8980860B2Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLGCOLLARD JOSEPH·Filed 2011·Granted Mar 17, 2015·0 cites·23 claims
- 2456US2017226516A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2015·Application pending·0 cites
- 2555US9834769B2Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1CURNA INC·Filed 2015·Granted Dec 5, 2017·0 cites·14 claims
- 2655US2011319476A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCOLLARD JOSEPH·Filed 2010·Application pending·0 cites
- 2754US9873873B2Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUACURNA INC·Filed 2015·Granted Jan 23, 2018·0 cites·17 claims
- 2852US11408004B2Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)CURNA INC·Filed 2015·Granted Aug 9, 2022·0 cites·17 claims
- 2952US10995334B2Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2CURNA INC·Filed 2016·Granted May 4, 2021·0 cites·10 claims
- 3052US9394542B2Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLGCURNA INC·Filed 2015·Granted Jul 19, 2016·0 cites·16 claims
- 3150US9023822B2Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAPCOLLARD JOSEPH·Filed 2010·Granted May 5, 2015·0 cites·15 claims
- 3250US8791087B2Treatment of ‘C terminus of HSP70-interacting protein’ (CHIP)related diseases by inhibition of natural antisense transcript to CHIPCOLLARD JOSEPH·Filed 2010·Granted Jul 29, 2014·0 cites·16 claims
- 3350US2012295952A1Treatment of filaggrin (flg) related diseases by modulation of flg expression and activityCOLLARD JOSEPH·Filed 2010·Application pending·0 cites
- 3449US2011237649A1Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1OPKO CURNA LLC·Filed 2009·Application pending·0 cites
- 3548US2013210893A1Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1COLLARD JOSEPH·Filed 2011·Application pending·0 cites
- 3643US2015368644A1Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1CURNA INC·Filed 2015·Application pending·0 cites
- 3741US2015031750A1Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnfSCRIPPS RESEARCH INST·Filed 2013·Application pending·0 cites
- 3835US2011319317A1Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1COLLARD JOSEPH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carlos Coito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →